Association of the multi-biomarker disease activity score with arterial 18-fluorodeoxyglucose uptake in rheumatoid arthritis
CONCLUSIONS: Among treated RA patients, achieved MBDA predicts of changes in arterial inflammation. Achieving low MBDA at 24 weeks was associated with clinically meaningful reductions in arterial inflammation, regardless of treatment.PMID:38652572 | DOI:10.1093/rheumatology/keae242
Source: Atherosclerosis - Category: Cardiology Authors: Jon T Giles Daniel H Solomon Katherine P Liao Pamela M Rist Zahi A Fayad Ahmed Tawakol Joan M Bathon Source Type: research
More News: Arthritis | Cardiology | CT Scan | Hydroxychloroquine | Methotrexate | PET Scan | Rheumatoid Arthritis | Rheumatology | Statistics